Preliminary results of the combined BlockACE2® Prevention and BlockACE2® functional food scheme for the prevention of COVID-19 in working population. Clinical trial , controlled, randomized, triple-blind, phase II.

Background: It is urgent to adopt public health measures and implement a preventive approach, its contagiousness and alleviate severe COVID-19, by reducing excessive inflammation. Purpose: To establish the efficacy and safety of the combined use of BlockACE2® oropharyngeal spray, and emulsion, in comparison with placebo on the reduction of the risk of infection by COVID-19,

Ver Más »
Ir arriba